Active Ingredient Acalabrutinib
Active Ingredient Details
What is the usage for Acalabrutinib?
This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors.
How many products in the NDC database contain Acalabrutinib?
The NDC database has 6 products with the active ingredient Acalabrutinib. The following table lists all the products that have this active ingredient.
NDC Products with Acalabrutinib
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0310-3512 | Proprietary Name: Calquence | Acalabrutinib | Tablet, Film Coated | Oral | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
| 0310-4513 | Proprietary Name: Calquence | Acalabrutinib | Tablet, Film Coated | Oral | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
| 17228-0512 | Proprietary Name: | Acalabrutinib | Capsule | Astrazeneca Ab | ACTIVE | ||
| 50683-0611 | Proprietary Name: | Acalabrutinib Maleate | Powder | American Pacific Corporation | ACTIVE | ||
| 53104-7746 | Proprietary Name: | Acalabrutinib | Powder | Cipla Ltd. | ACTIVE | ||
| 54893-0108 | Proprietary Name: | Acalabrutinib | Powder | Msn Laboratories Private Limited | ACTIVE |
